Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association between XPD Lys751Gln polymorphism and risk of head and neck cancer: a meta-analysis.

Genetics and molecular research : GMR - 22 Nov 2011

Yuan H, Niu Y M, Wang R X, Li H Z, Chen N

Abstract excerpt

Several studies have investigated the association between Lys751Gln polymorphism in the xeroderma pigmentosum group D (XPD) gene and risk of head and neck cancer; however, the published results are conflicting. We conducted a meta-analysis that comprised 15 published case-control studies examining the association of head and neck cancer risk with XPD Lys751Gln polymorphism in different populations, based on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Substitution
Share to Case-Control Studies
Share to Genetic Association Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Head and Neck Neoplasms

Share to Odds Ratio

Share to Publication Bias

Share to Risk Factors

Share to Xeroderma Pigmentosum Group D Protein

Source

Identifiers

PMID: 22179996
DOI: 10.4238/2011.November.22.6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association between XPD Lys751Gln polymorphism and risk of head and neck cancer: a meta-analysis.PMID 22179996Read ↗

Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects.Semantic proximity Read ↗

XPD Lys751Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis.Semantic proximity Read ↗

XPD Lys751Gln polymorphism and esophageal cancer susceptibility: a meta-analysis of case-control studies.Semantic proximity Read ↗

XPD Lys751Gln polymorphisms and the risk of esophageal cancer: an updated meta-analysis.Semantic proximity Read ↗

Association between the XPD/ERCC2 Lys751Gln polymorphism and risk of cancer: evidence from 224 case-control studies.Semantic proximity Read ↗

XPD Lys751Gln polymorphism and esophageal cancer risk: a meta-analysis involving 2288 cases and 4096 controls.Semantic proximity Read ↗

Genetic Association between the XPG Asp1104His Polymorphism and Head and Neck Cancer Susceptibility: Evidence Based on a Meta-Analysis.Semantic proximity Read ↗

Association between XPD Lys751Gln polymorphism and bladder cancer susceptibility: an updated and cumulative meta-analysis based on 6,836 cases and 8,251 controls.Semantic proximity Read ↗

The effect of XPD polymorphisms on digestive tract cancers risk: a meta-analysis.Semantic proximity Read ↗

XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects.Semantic proximity Read ↗

XPD Lys751Gln and Asp312Asn polymorphisms and gastric cancer susceptibility: a meta-analysis of case-control studies.Semantic proximity Read ↗

Association between XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma risk: a systematic review and meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.